NAFDAC cautions patent medicine dealers against substandard drugs
by Adenle Ahmed Abiola · The Eagle OnlineThe Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof Moji Adeyeye, has emphasised the urgent need for stringent measures to combat substandard and falsified medical products in the country.
This was as the DG warned members of the Nigerian Association of Patent and Proprietary Medicine Dealers (NAPPMED) against the purchase and sale of substandard drugs.
The DG, represented by the agency’s Director of Post-Marketing Surveillance, Fraden Bitrus, gave the warning to the NAPPMED members during a one-day sensitisation campaign in Abuja on Monday.
“Today, we discuss a crucial issue: sourcing quality products for our communities,” Bitrus stated.
He underscored the importance of prioritising community welfare over financial gain, urging participants to recognise their significant role as healthcare professionals.
- Spotify’s soundtrack of Independence celebrates Nigeria’s music
- Bobrisky absent, as VeryDarkMan, EFCC, others honour Reps summon
- Hotel inspection: Edo warns Shaibu not to act in breach of extant laws
- Independence Day Celebration: IBEDC reaffirms commitment to national development
- Nigeria at 64: Harvest of despondency, hunger and poverty, by Richard Odusanya
“Your services directly impact community welfare. It is essential to prioritize their well-being,” he said
Key strategies for avoiding falsified products, as outlined by Bitrus, include sourcing from reputable suppliers and ensuring all products meet regulatory standards.
“To avoid falsified products, you must source products correctly and verify their compliance with NAFDAC regulations.
“Let’s unite against falsified products. Support NAFDAC’s efforts to eradicate harmful products from our markets,” he advised.
Bitrus reiterated the key takeaways of the campaign, reminding attendees to prioritize community welfare, source quality products, and uphold their professional responsibilities.
“Let’s work together to ensure Nigeria has access to quality products,” he concluded, stressing the collective responsibility of stakeholders in the fight against substandard drugs.
Post Views: 10